Metastatic or locally advanced mediastinal neuroendocrine tumours: outcome with 177Lu-DOTATATE-based peptide receptor radionuclide therapy and assessment of prognostic factors

No Thumbnail Available

Click here to download

1127.htm (5.47 KB)

Date

2019

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

177Lu-DOTATATE, mediastinal neuroendocrine tumour, neuroendocrine tumour, peptide receptor radionuclide therapy, thymic neuroendocrine tumour

Source

Nuclear Medicine Communications, 2019. Vol. 40 (9)

URI

http://hdl.handle.net/123456789/21429

Collections

2019